BIOF Stock Overview
Blue Biofuels, Inc., through its subsidiaries, focuses on technologies in the renewable energy, biofuels, and bioplastics technologies sectors.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Blue Biofuels, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.088 |
| 52 Week High | US$0.18 |
| 52 Week Low | US$0.055 |
| Beta | -0.25 |
| 1 Month Change | -11.65% |
| 3 Month Change | -33.00% |
| 1 Year Change | -45.76% |
| 3 Year Change | -73.59% |
| 5 Year Change | 115.70% |
| Change since IPO | -93.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOF | US Oil and Gas | US Market | |
|---|---|---|---|
| 7D | 0.6% | -1.0% | -3.2% |
| 1Y | -45.8% | 12.8% | 19.3% |
Return vs Industry: BIOF underperformed the US Oil and Gas industry which returned 12.8% over the past year.
Price Volatility
| BIOF volatility | |
|---|---|
| BIOF Average Weekly Movement | 12.2% |
| Oil and Gas Industry Average Movement | 4.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Volatility Over Time: BIOF's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 6 | Ben Slager | www.bluebiofuels.com |
Blue Biofuels, Inc., through its subsidiaries, focuses on technologies in the renewable energy, biofuels, and bioplastics technologies sectors. The company develops Cellulose-to-Sugar (CTS 2.0), a mechanical/chemical dry process for converting cellulose material into sugar and lignin for use in the biofuels industry. It also has license for Vertimass Process to convert ethanol into bio-jet fuel.
Blue Biofuels, Inc. Fundamentals Summary
| BIOF fundamental statistics | |
|---|---|
| Market cap | US$25.19m |
| Earnings (TTM) | -US$3.06m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-8.8x
P/E RatioIs BIOF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOF income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$3.06m |
| Earnings | -US$3.06m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.01 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -96.5% |
How did BIOF perform over the long term?
See historical performance and comparison